Compare AstraZeneca plc (AZN) vs Dow Inc (DOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Dow Inc — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Dow Inc trades at $31.07 (market cap $22.58B). The key difference: AstraZeneca plc is far larger — about 11× Dow Inc's market cap, and Dow Inc pays the higher dividend (4.48%). Which is the better fit depends on your goals.
| AZN | DOW | |
|---|---|---|
Market Cap | $248.14B | $22.58B |
Sector | Health | Basic Materials |
52-Week High | $209.48 | $41.87 |
52-Week Low | $147.06 | $20.65 |
Enterprise Value | $275.41B | $38.27B |
Dividend Yield | 2.01% | 4.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →
